Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any retinopathy caused by variants in the PDE6G gene.
Biomarker and diagnostic research for PDE6G-related retinopathy has been reported in the published literature.
No clinical trials have been registered for PDE6G-related retinopathy.
208 publications have been identified in PubMed for PDE6G-related retinopathy. Kisho has analyzed 115 by research type. Research spans Review / Meta-Analysis (54%), Basic Science / Preclinical (21%), and Epidemiology / Natural History (11%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 62 | 54% |
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 3:04 AM UTC
Common questions about PDE6G-related retinopathy
Laboratory research
24 |
21% |
Disease patterns and progression | 13 | 11% |
Testing and diagnosis research | 5 | 4% |
Patient case studies | 5 | 4% |
Clinical study results | 3 | 3% |
New treatment approaches | 2 | 2% |
Other research | 1 | 1% |
Marmor MF (2026). [PMID: 41232611](https://pubmed.ncbi.nlm.nih.gov/41232611/). *Ophthalmology*. [Review / Meta-Analysis]
Mukundan A (2026). [PMID: 41316839](https://pubmed.ncbi.nlm.nih.gov/41316839/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Selim MS (2026). [PMID: 41827851](https://pubmed.ncbi.nlm.nih.gov/41827851/). *Cells*. [Review / Meta-Analysis]
Reichel FF (2026). [PMID: 40825661](https://pubmed.ncbi.nlm.nih.gov/40825661/). *Br J Ophthalmol*. [Clinical Trial Publication]
Wu C (2026). [PMID: 41694560](https://pubmed.ncbi.nlm.nih.gov/41694560/). *Front Endocrinol (Lausanne)*. [Review / Meta-Analysis]
Harlow REA (2026). [PMID: 42079665](https://pubmed.ncbi.nlm.nih.gov/42079665/). *Front Immunol*. [Review / Meta-Analysis]
Zhao CS (2026). [PMID: 41608829](https://pubmed.ncbi.nlm.nih.gov/41608829/). *Curr Opin Ophthalmol*. [Review / Meta-Analysis]
Wang X (2026). [PMID: 41662529](https://pubmed.ncbi.nlm.nih.gov/41662529/). *Proc Natl Acad Sci U S A*. [Basic Science / Preclinical]
Niaudet C (2026). [PMID: 41271176](https://pubmed.ncbi.nlm.nih.gov/41271176/). *Radiother Oncol*. [Review / Meta-Analysis]
Land MR (2026). [PMID: 41750360](https://pubmed.ncbi.nlm.nih.gov/41750360/). *Biomolecules*. [Review / Meta-Analysis]